MEDIROM Healthcare TechnologiesMRM -4.43%53 PB Ratio is 5.02 as of Jun. 24, 2026, which is 30% below its 10-year median of 7.15. GuruFocus rates MRM with a GF Score™ of 53/100 and a GF Value™ of $4.08 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 90 Personal Services companies, MEDIROM Healthcare Technologies ranks worse than 86.67% on this metric.
MEDIROM Healthcare Technologies Inc stock PB Ratio (=5.26) is close to 1-year high of 5.26.
The historical rank and industry rank for MEDIROM Healthcare Technologies's PB Ratio or its related term are showing as below:
MRM'
s PB Ratio Range Over the Past 10 Years
Min: 0.47 Med: 7.15 Max: 21
Current: 5.1
During the past 7 years, MEDIROM Healthcare Technologies's highest PB Ratio was 21.00. The lowest was 0.47. And the median was 7.15.
MRM's PB Ratio is ranked worse than 86.67% of 90
companies
in the Personal Services industry
Industry Median: 1.48
vs MRM: 5.10
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of MEDIROM Healthcare Technologies was -19.30% per year. The lowest was -32.60% per year. And the median was -25.95% per year.
Back to Basics: PB Ratio
MEDIROM Healthcare Technologies (NAS:MRM) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
MEDIROM Healthcare Technologies PB Ratio Related Terms
MEDIROM Healthcare Technologies PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Personal Services subindustry, MEDIROM Healthcare Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDIROM Healthcare Technologies PB Ratio vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, MEDIROM Healthcare Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where MEDIROM Healthcare Technologies's PB Ratio falls into.
MEDIROM Healthcare Technologies PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
MEDIROM Healthcare Technologies (MRM) has a PB Ratio of 5.02 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MEDIROM Healthcare Technologies and its competitors. This is 30% below median its historical median of 7.15. Over the past decade, MEDIROM Healthcare Technologies' PB Ratio has ranged from 0.47 to 21.00. According to the industry distribution chart, MEDIROM Healthcare Technologies ranks #78 out of 90 companies in the Personal Services industry, placing it in the top 86.7%.
Is MEDIROM Healthcare Technologies' PB Ratio too high?
MEDIROM Healthcare Technologies' current PB Ratio of 5.02 is 30% below median its 10-year median of 7.15. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 21.00. The Personal Services industry median PB Ratio is 1.48. MEDIROM Healthcare Technologies' value of 5.02 is 239.2% above this industry median. Based on the distribution chart, MEDIROM Healthcare Technologies ranks #78 out of 90 companies in the Personal Services industry, which is in the bottom quartile relative to peers. Overall, MEDIROM Healthcare Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MEDIROM Healthcare Technologies' PB Ratio compare to DROR and CLIK?
According to the Personal Services industry distribution chart, MEDIROM Healthcare Technologies ranks #78 out of 90 companies for PB Ratio. This places MEDIROM Healthcare Technologies in the lower half of its industry. The industry median PB Ratio is 1.48. MEDIROM Healthcare Technologies' value of 5.02 is 239.2% above this benchmark. Historically, MEDIROM Healthcare Technologies' own PB Ratio has ranged from 0.47 to 21.00 over the past decade. While the company's 10-year median is 7.15 vs. the industry median of 1.48, MEDIROM Healthcare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Personal Services company?
The median PB Ratio among Personal Services companies is 1.48, based on 90 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDIROM Healthcare Technologies's current PB Ratio of 5.02 is 239.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MEDIROM Healthcare Technologies and its competitors. For the Personal Services industry, the median PB Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDIROM Healthcare Technologies's current PB Ratio is 5.02, which is 30% below median its own 10-year median of 7.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDIROM Healthcare Technologies stock overvalued right now?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies (MRM) is currently considered Possible Value Trap. The stock's GF Value™ is $4.08, compared to a current price of $1.07 — trading 73.8% below its estimated fair value. The current PB Ratio is 5.02, which is 30% below median its 10-year median of 7.15 and 239.2% above the Personal Services industry median of 1.48. MEDIROM Healthcare Technologies' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MEDIROM Healthcare Technologies (MRM), the current PB Ratio is 5.02 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDIROM Healthcare Technologies (MRM) Overvalued in 2026?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies stock appears to be undervalued.
The current stock price of $1.07 is trading 73.8% below its estimated GF Value™ of $4.08.
GuruFocus considers MEDIROM Healthcare Technologies to be Possible Value Trap.
Key valuation signals for MRM:
PB Ratio: 5.02 (30% below median its 10-year median of 7.15)
GF Value™: $4.08 vs. price of $1.07 (73.8% below fair value)
Industry Position: 239.2% above the Personal Services median (#78 of 90)
No single metric tells the full story. See the MRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDIROM Healthcare Technologies Business Description
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
53GF Score
Get the complete analysis for MRM
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRM has been successfully added to your 
